To ask the Secretary of State for Northern Ireland what services are provided for people with chronic fatigue syndrome on the NHS in the Province.

To ask the Secretary of State for Northern Ireland what services are provided for people with chronic fatigue syndrome on the NHS in the Province.

To ask the Secretary of State for Northern Ireland what funding has been provided for people with chronic fatigue syndrome in each of the last five years.

To ask the Secretary of State for Northern Ireland what funding has been provided for people with chronic fatigue syndrome in each of the last five years.

Further to the Written Answer by the Lord Sainsbury of Turville on 16 October (WA 174), what study the Medical Research Council has made of the research on immune abnormalities associated with chronic fatigue syndrome at the University of Miami School of Medicine and its possible relevance to illnesses among...

Further to the Written Answer by the Lord Sainsbury of Turville on 16 October (WA 174), what study the Medical Research Council has made of the research on immune abnormalities associated with chronic fatigue syndrome at the University of Miami School of Medicine and its possible relevance to illnesses among...

To ask the Secretary of State for Health what measures the Government are undertaking to ensure that adequate research is undertaken into the (a) causes and (b) treatment of myalgic encephalopathy.

To ask the Secretary of State for Health what measures the Government are undertaking to ensure that adequate research is undertaken into the (a) causes and (b) treatment of myalgic encephalopathy.

To ask the Secretary of State for Health what representations she has received on the provision of the chronic fatigue service in Leeds and West Yorkshire; and whether the value of her Department's direct funding for the service will be maintained in real terms over the next three years.

To ask the Secretary of State for Health what representations she has received on the provision of the chronic fatigue service in Leeds and West Yorkshire; and whether the value of her Department's direct funding for the service will be maintained in real terms over the next three years.

To ask the Secretary of State for Health (1) what assessment she has made of the merits of specialist services to treat myalgic encephalomyelitis sufferers;

To ask the Secretary of State for Health (1) what assessment she has made of the merits of specialist services to treat myalgic encephalomyelitis sufferers;

To ask the Secretary of State for Health what estimate she has made of the cost in a year to the economy of myalgic encephalomyelitis; and how much was spent on health services for myalgic encephalomyelitis sufferers in the last period for which figures are available.

To ask the Secretary of State for Health what estimate she has made of the cost in a year to the economy of myalgic encephalomyelitis; and how much was spent on health services for myalgic encephalomyelitis sufferers in the last period for which figures are available.

(2) what assessment she has made of the effect of budgetary pressures within the NHS on specialist services for myalgic encephalomyelitis sufferers.

(2) what assessment she has made of the effect of budgetary pressures within the NHS on specialist services for myalgic encephalomyelitis sufferers.

To ask the Secretary of State for Health what steps she plans to take to ensure that primary care trusts continue to provide specialist myalgic encephalomyelitis and encephalopathy services after their reconfiguration in October 2006; and if she will make a statement.

To ask the Secretary of State for Health what steps she plans to take to ensure that primary care trusts continue to provide specialist myalgic encephalomyelitis and encephalopathy services after their reconfiguration in October 2006; and if she will make a statement.

(4) what assessment she has made of the contribution made by specialist myalgic encephalomyelitis and encephalopathy services to the public and patient involvement initiative.

(4) what assessment she has made of the contribution made by specialist myalgic encephalomyelitis and encephalopathy services to the public and patient involvement initiative.

(3) what assessment she has made of (a) the impact of any reduction in myalgic encephalomyelitis and encephalopathy (ME) services on the continued viability of whole service provision to people with ME and (b) the availability of other treatments by non-specialists to mitigate such reductions;

(3) what assessment she has made of (a) the impact of any reduction in myalgic encephalomyelitis and encephalopathy (ME) services on the continued viability of whole service provision to people with ME and (b) the availability of other treatments by non-specialists to mitigate such reductions;

To ask the Secretary of State for Health what specialist myalgic encephalomyelitis/encephaliopathy and chronic fatigue syndrome services are being provided under the public patient initiative; and if she will make a statement.

To ask the Secretary of State for Health what specialist myalgic encephalomyelitis/encephaliopathy and chronic fatigue syndrome services are being provided under the public patient initiative; and if she will make a statement.

To ask the Secretary of State for Health (1) what her policy is on the future provision of specialist myalgic encephalomyelitis and encephalopathy services by primary care trusts;

To ask the Secretary of State for Health (1) what her policy is on the future provision of specialist myalgic encephalomyelitis and encephalopathy services by primary care trusts;

(2) whether funding for specialist myalgic encephalomyelitis and encephalopathy (ME) services is contained within the baseline budgets of primary care trusts; and what assessment she has made of the impact of the forthcoming restructuring of primary care trusts on the continued funding for specialist ME services;

(2) whether funding for specialist myalgic encephalomyelitis and encephalopathy (ME) services is contained within the baseline budgets of primary care trusts; and what assessment she has made of the impact of the forthcoming restructuring of primary care trusts on the continued funding for specialist ME services;

To ask the Secretary of State for Work and Pensions how many individuals diagnosed with myalgic encephalomyelitis qualified for disability living allowance in (a) 2004 and (b) 2005.

To ask the Secretary of State for Work and Pensions how many individuals diagnosed with myalgic encephalomyelitis qualified for disability living allowance in (a) 2004 and (b) 2005.

(2) how many individuals diagnosed with myalgic encephalomyelitis applied but failed to qualify for disability living allowance in (a) 2003, (b) 2004 and (c) 2005.

(2) how many individuals diagnosed with myalgic encephalomyelitis applied but failed to qualify for disability living allowance in (a) 2003, (b) 2004 and (c) 2005.

To ask the Secretary of State for Work and Pensions (1) how many individuals diagnosed with myalgic encephalomyelitis who failed to qualify for disability living allowance appealed against the decision in (a) 2003, (b) 2004 and (c) 2005;

To ask the Secretary of State for Work and Pensions (1) how many individuals diagnosed with myalgic encephalomyelitis who failed to qualify for disability living allowance appealed against the decision in (a) 2003, (b) 2004 and (c) 2005;

To ask the Secretary of State for Work and Pensions what arrangements are in place to ensure that medical tribunals for individuals diagnosed with myalgic encephalomyelitis who are housebound are held in a location convenient for the claimant.

To ask the Secretary of State for Work and Pensions what arrangements are in place to ensure that medical tribunals for individuals diagnosed with myalgic encephalomyelitis who are housebound are held in a location convenient for the claimant.

To ask the Secretary of State for Work and Pensions, how many individuals diagnosed with myalgic encephalomyelitis who attended a medical tribunal were successful in (a) 2003, (b) 2004 and (c) 2005.

To ask the Secretary of State for Work and Pensions, how many individuals diagnosed with myalgic encephalomyelitis who attended a medical tribunal were successful in (a) 2003, (b) 2004 and (c) 2005.

To ask the Secretary of State for Trade and Industry what research he has (a) commissioned and (b) evaluated into genetic abnormalities in white blood cells of myalgic encephalopathy and encephalomyelitis sufferers; and if he will make a statement.

To ask the Secretary of State for Trade and Industry what research he has (a) commissioned and (b) evaluated into genetic abnormalities in white blood cells of myalgic encephalopathy and encephalomyelitis sufferers; and if he will make a statement.